As of 2025-07-04, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 19.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.98 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -37.6%.
The range of the Relative Valuation is 12.36 - 28.78 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 20.6x | 13.6x |
| Forward P/E multiples | 13.8x - 20.3x | 17.5x |
| Fair Price | 12.36 - 28.78 | 19.95 |
| Upside | -61.3% - -10.0% | -37.6% |
| Date | P/E |
| 2025-07-03 | 28.92 |
| 2025-07-02 | 29.00 |
| 2025-07-01 | 28.78 |
| 2025-06-30 | 28.50 |
| 2025-06-27 | 28.18 |
| 2025-06-26 | 28.21 |
| 2025-06-25 | 28.25 |
| 2025-06-24 | 28.64 |
| 2025-06-23 | 28.93 |
| 2025-06-20 | 29.19 |
| 2025-06-18 | 29.81 |
| 2025-06-17 | 29.23 |
| 2025-06-16 | 29.36 |
| 2025-06-13 | 28.97 |
| 2025-06-12 | 29.63 |
| 2025-06-11 | 29.98 |
| 2025-06-10 | 30.08 |
| 2025-06-09 | 30.09 |
| 2025-06-06 | 29.98 |
| 2025-06-05 | 29.25 |
| 2025-06-04 | 29.21 |
| 2025-06-03 | 29.15 |
| 2025-06-02 | 28.86 |
| 2025-05-30 | 28.67 |
| 2025-05-29 | 28.65 |
| 2025-05-28 | 29.07 |
| 2025-05-27 | 29.48 |
| 2025-05-23 | 29.03 |
| 2025-05-22 | 28.97 |
| 2025-05-21 | 29.51 |
| 2025-05-20 | 30.02 |
| 2025-05-19 | 29.89 |
| 2025-05-16 | 30.23 |
| 2025-05-15 | 29.37 |
| 2025-05-14 | 28.52 |
| 2025-05-13 | 29.19 |
| 2025-05-12 | 29.07 |
| 2025-05-09 | 28.67 |
| 2025-05-08 | 28.52 |
| 2025-05-07 | 27.98 |
| 2025-05-06 | 29.33 |
| 2025-05-05 | 29.29 |
| 2025-05-02 | 29.70 |
| 2025-05-01 | 29.35 |
| 2025-04-30 | 29.37 |
| 2025-04-29 | 29.38 |
| 2025-04-28 | 29.16 |
| 2025-04-25 | 29.14 |
| 2025-04-24 | 28.35 |
| 2025-04-23 | 27.89 |